InvestorsHub Logo
Followers 12
Posts 1060
Boards Moderated 0
Alias Born 06/29/2017

Re: None

Monday, 01/25/2021 9:06:31 AM

Monday, January 25, 2021 9:06:31 AM

Post# of 6042
Looks like HTBX is now officially on the path to $50 per share with the news release that they are commencing production of ZVX-60:

DURHAM, NC / ACCESSWIRE / January 19, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announces it has transferred its gp96-based COVID-19 vaccine cell line ("ZVX-60") to Waisman Biomanufacturing to initiate the manufacturing process for ZVX-60, which is being developed for use as either a standalone vaccine, or in combination with other vaccines, to enhance prophylactic protection against COVID-19.

EVERYONE SHOULD BE BUYING THIS STOCK BIG TIME IT IS JUST OVER A DOLLAR PRE REVERSE SPLIT OF 1 FOR 7
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHWK News